Optiver Holding
PROF

Optiver Holding’s Profound Medical PROF Stock Holding History

Optiver Holding’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,227
Closed -$11K – 492
2022
Q1 		$11K Buy
1,227
+887
+261% +$8.54K ﹤0.01% 425
2021
Q4 		$4K Buy
+340
New +$4.25K ﹤0.01% 813

Other funds holding PROF

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Optiver Holding's PROF Position: Q2 2022 in Review

Optiver Holding sold out of Profound Medical (PROF) in Q2 2022, closing a stake of 1,227 shares — an estimated $11K sold.

Optiver Holding first reported a position in PROF in Q4 2021 and held it in 2 quarters. The position peaked at $11K in Q1 2022. 39 funds tracked by Wall St. Rank hold PROF as of Q2 2022.

  • Optiver Holding reported no remaining Profound Medical position as of Q2 2022 after selling out during the quarter.
  • Optiver Holding sold 1,227 Profound Medical shares in Q2 2022, an estimated $11K.
  • Optiver Holding first reported a position in Profound Medical in Q4 2021 and held it in 2 quarters.
  • Optiver Holding's Profound Medical position peaked at $11K in Q1 2022.
  • 39 funds tracked by Wall St. Rank held Profound Medical as of Q2 2022.

Based on Optiver Holding's 13F filing for Q2 2022, filed 10 Aug 2022.